StockData
Starling Oncology, Inc. logo

Starling Oncology, Inc. (STLN) stock

STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.40−0.14 (-3.95%)

Close on Nov 17, 2026Market cap $346.52MP/E –Yield –

Starling Oncology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Starling Oncology's enterprise value was $460.74M on Nov 11, 2026, against $354.91M a year earlier. Over the last 5 years it ranged from $44.18M to $694.84M, with a median of $212.72M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$460.74M+16.4%
2025Dec 31, 2025$395.89M+486.6%
2024Dec 31, 2024$67.48M-54.5%
2023Dec 29, 2023$148.25M+37.5%
2022Dec 30, 2022$107.85M-49.3%
2021Dec 31, 2021$212.72M+248.1%
2020Dec 31, 2020$61.10M–

More Starling Oncology figures

See a number that looks wrong?